Valuation is generally based on three approaches: income, market, and asset. Appraisers need to make choices among these approaches, often applying weightings between them, and that choice can result in substantially different valuations of the same company. How does the court decide.....
Read More
The question for valuators and M&A advisers is no longer whether tariffs matter to value. It’s who absorbs the cost. Small and moderate tariffs often behave like a tax, while large tariffs can become a trade barrier that changes the structure of the market itself.....
Read More
M&A Deal Economics Series — Part 2. After more than 25 years working on M&A transactions, first as a corporate tax and M&A lawyer and now as an M&A advisor, I have seen many deals where Buyer and Seller agree on almost everything, except what the business is worth. An earnout can sometimes bridge that gap.....
Read More
Valuation in Shareholder Disputes — Part 2. Valuation issues are some of the most impactful in shareholder disputes. An important, but perhaps underappreciated, issue in these disputes is how to account for a company’s tax status.....
Read More
After more than 25 years working on M&A transactions, first as a corporate tax and M&A lawyer and now as an M&A advisor, I have seen many transactions where the parties spend considerable time negotiating the headline purchase price, only to discover that another number can have a significant impact on the seller’s ultimate proceeds: Working capital.....
Read More
Valuation in Shareholder Disputes — Part 1. The endgame in co-owner disputes is very often a buyout. And where the case is heading toward a buyout, the valuation is not a detail of the remedy. The valuation is the remedy.....
Read More
For the better part of the past decade, the standard architecture for private investment in physician practices has been the management services organization (“MSO”) structure. Instead of owning a physician practice, investors have created MSOs to handle billing, real estate, HR, and back-office operations.....
Read More
Healthcare dealmakers are not slowing down. According to KPMG’s mid-2025 M&A trends update, 61% of investors expected increased M&A activity in 2025 compared to 2024. That optimism proved directionally right for the market overall, though not for healthcare services specifically.....
Read More
As the world hits the age of artificial intelligence (“AI”), which has just begun, development will be as crucial as the creation of the personal computer, the Internet, or the mobile phone. Investors, management teams, and everyday participants have begun to take notice and adapt. The impact, from labor to health care to automotive, will be profound....
Read More
It has been said that inflation is taxation without legislation. While there have been numerous discussions on whether inflation is transitory or permanent, we believe that there are arguments to be made on both sides. Each scenario has implications when considering business valuations and mergers and acquisitions....
Read More
COVID-19 has had a significant impact, whether temporarily or permanently, on the earnings and value of many businesses. With the news of the vaccine rollout, temporary impacts, which started with the pandemic lockdowns, should soon start to fade. However, the value of a business could vary significantly depending on the....
Read More
Examining the Mandelbaum factors and the 10 factors that one should consider in determining the appropriate marketability discount on private company common shares. The 10 factors can also be considered a guide to analyzing risk, from one perspective, of public company shares.....
Read More